GL-0719

N/A

Report date: 2022/04/15 13:47:34

Base Information

Drug NameGL-0719

Drug Alias NameGL-0719

ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein

Mechanisms of ActionComplement C1q subcomponent inhibitors

TargetsComplement C1q subcomponent

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGliknik Inc

China Registration ClassN/A

Active CompaniesGliknik Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A